Jonathan Monson - 01 Jul 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
EVP and CFO
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
01 Jul 2025
Net transactions value
$0
Form type
4
Filing time
02 Jul 2025, 16:09:43 UTC
Previous filing
30 Jun 2025
Next filing
04 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Monson Jonathan EVP and CFO 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH /s/ Susan Thompson, Attorney-in-Fact 02 Jul 2025 0001779170

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Award $0 +8,350 $0.000000 8,350 01 Jul 2025 Common Stock 8,350 Direct F1, F2
transaction BSX Stock Option (Right to Buy) Award $0 +22,173 $0.000000 22,173 01 Jul 2025 Common Stock 22,173 $104.78 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.
F3 Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on July 1, 2026, the first anniversary of the date of grant.